Public insurance tied to lower cancer survival in young patients

(HealthDay)—Young, low-income patients with bone or soft tissue sarcomas have decreased overall survival (OS), regardless of disease stage at presentation, according to a study published online Dec. 1

Updated on: December 22,2023

Public insurance tied to lower cancer survival in young patients

(HealthDay)—Young, low-income patients with bone or soft tissue sarcomas have decreased overall survival (OS), regardless of disease stage at presentation, according to a study published online Dec. 1

Updated on:December 22,2023

Molecular tumor boards improve outcomes for patients with advanced cancer

by Elizabeth Chapin,University of KentuckyWaterfall plot detailing individual PFS ratio (PFS2/PFS1) values for patients treated with second-line or greater-line MTB-directed therapy (cohort 1; n

Updated on: December 22,2023

Molecular tumor boards improve outcomes for patients with advanced cancer

by Elizabeth Chapin,University of KentuckyWaterfall plot detailing individual PFS ratio (PFS2/PFS1) values for patients treated with second-line or greater-line MTB-directed therapy (cohort 1; n

Updated on:December 22,2023

Research raises hope for new therapies for chordoma, a rare bone cancer

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsChordoma is literally a one in a million cancer, with few effective treatment options. A new unde

Updated on: May 31,2024

Research raises hope for new therapies for chordoma, a rare bone cancer

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsChordoma is literally a one in a million cancer, with few effective treatment options. A new unde

Updated on:May 31,2024

Transistors help identify cancer cell markers

by Tokyo Medical and Dental UniversityIon-sensitive field effect transistors detect breast cancer cells expressing EGFR when bound by an antibody linked to a chemical reporter. Credit: Department of B

Updated on: December 26,2023

Transistors help identify cancer cell markers

by Tokyo Medical and Dental UniversityIon-sensitive field effect transistors detect breast cancer cells expressing EGFR when bound by an antibody linked to a chemical reporter. Credit: Department of B

Updated on:December 26,2023

Most U.S. children have adequate geographic access to cancer care

by Lori SolomonMost U.S. children and adolescents and young adults (AYAs) have adequate access to pediatric cancer care, according to a study published online Jan. 19 inJAMA Network Open.Xiaohui

Updated on: December 20,2023

Most U.S. children have adequate geographic access to cancer care

by Lori SolomonMost U.S. children and adolescents and young adults (AYAs) have adequate access to pediatric cancer care, according to a study published online Jan. 19 inJAMA Network Open.Xiaohui

Updated on:December 20,2023

Combining immunotherapy with KRAS inhibitor eliminates advanced KRAS-mutant pancreatic cancer in preclinical models

by University of Texas M. D. Anderson Cancer CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainResearchers at The University of Texa

Updated on: January 30,2024

Combining immunotherapy with KRAS inhibitor eliminates advanced KRAS-mutant pancreatic cancer in preclinical models

by University of Texas M. D. Anderson Cancer CenterAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainResearchers at The University of Texa

Updated on:January 30,2024

Top medical groups, hospitals urge better access to lung cancer screening

by Cara MurezScreening tests routinely catch cases of breast and colon cancer early, but a screening test for lung cancer is sorely underused in high-risk people and that needs to change, more than 50

Updated on: December 20,2023

Top medical groups, hospitals urge better access to lung cancer screening

by Cara MurezScreening tests routinely catch cases of breast and colon cancer early, but a screening test for lung cancer is sorely underused in high-risk people and that needs to change, more than 50

Updated on:December 20,2023

The way genes are switched on in one-cell embryos may resemble the trigger for cancer

byUniversity of BathGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112023When an embryo is formed, its genes—donated by a fertilizing sperm and egg—are sil

Updated on: December 25,2023

The way genes are switched on in one-cell embryos may resemble the trigger for cancer

byUniversity of BathGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112023When an embryo is formed, its genes—donated by a fertilizing sperm and egg—are sil

Updated on:December 25,2023

Diabetes medication class tied to lower risk of kidney stones

by Mass General BrighamCredit: Pixabay/CC0 Public DomainRates of kidney stones are on the rise in the United States and around the world. Type 2 diabetes is associated with increased risk of kidn

Updated on: May 26,2024

Diabetes medication class tied to lower risk of kidney stones

by Mass General BrighamCredit: Pixabay/CC0 Public DomainRates of kidney stones are on the rise in the United States and around the world. Type 2 diabetes is associated with increased risk of kidn

Updated on:May 26,2024

6 months treatment with Herceptin is as good as 12 months for preventing breast cancer return

by Peter Thorley,University of WarwickCredit: CC0 Public DomainA new study co-led by the University of Warwick Clinical Trials Unit has shown that shortening the duration of a therapy for breast

Updated on: March 14,2024

6 months treatment with Herceptin is as good as 12 months for preventing breast cancer return

by Peter Thorley,University of WarwickCredit: CC0 Public DomainA new study co-led by the University of Warwick Clinical Trials Unit has shown that shortening the duration of a therapy for breast

Updated on:March 14,2024

Is this a faster, better treatment for blood and solid tumor cancers?

by Cynthia McCormick Hibbert,Northeastern UniversityCredit: Alyssa Stone/Northeastern UniversityA Northeastern researcher in the Department of Pharmaceutical Sciences and the New England Inflamm

Updated on: January 26,2024

Is this a faster, better treatment for blood and solid tumor cancers?

by Cynthia McCormick Hibbert,Northeastern UniversityCredit: Alyssa Stone/Northeastern UniversityA Northeastern researcher in the Department of Pharmaceutical Sciences and the New England Inflamm

Updated on:January 26,2024

Predicting prostate cancer recurrence 15 months sooner

by Steve Martin,Purdue UniversityGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.105430A Purdue University mechanical engineer and his international collaborators

Updated on: January 06,2024

Predicting prostate cancer recurrence 15 months sooner

by Steve Martin,Purdue UniversityGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.105430A Purdue University mechanical engineer and his international collaborators

Updated on:January 06,2024